#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14976	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2439	737.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1673	1673	C	909	C,G,A	906,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25062	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4143	753.9	0	.	n	.	0	T695C	SNP	695	695	T	1306	1306	C	943	C,A,T	941,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25062	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4143	753.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1948	1948	A	1055	A,G	1053,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25062	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4143	753.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2582	2582	C	876	C,A	875,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25062	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4143	753.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2656	2656	A	833	A,C	831,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25062	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4143	753.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3208	3208	C	865	C,G	862,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2180	folP	855	855	100.0	folP.l15.c4.ctg.1	2203	123.5	1	SNP	p	R229S	0	.	.	685	687	CGC	1410	1412	CGC	216;221;220	C,A;G;C	215,1;221;220	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5414	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3894	173.2	1	SNP	p	S91F	0	.	.	271	273	TCC	863	865	TCC	203;205;205	T,A;C;C	201,2;205;205	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5414	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3894	173.2	1	SNP	p	D95G	0	.	.	283	285	GAC	875	877	GAC	218;221;219	G;A,C;C	218;220,1;219	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5414	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3894	173.2	1	SNP	p	D95N	0	.	.	283	285	GAC	875	877	GAC	218;221;219	G;A,C;C	218;220,1;219	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	27	1956	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1828	133.2	1	SNP	p	G45D	0	.	.	133	135	GGC	806	808	GGC	210;208;209	G;G;C,G	210;208;208,1	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1100	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1517	90.2	0	.	n	.	0	.206T	INS	206	206	T	852	852	T	221	T	221	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4898	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3563	171.5	1	SNP	p	D86N	0	.	.	256	258	GAC	849	851	GAC	230;232;232	G;A,C;C,T	230;231,1;231,1	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4898	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3563	171.5	1	SNP	p	S88P	0	.	.	262	264	TCC	855	857	TCC	231;229;228	T;C,T,G;C	231;227,1,1;228	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4244	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3184	165.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1795	1797	GGC	226;224;224	G;G;C,A	226;224;223,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3890	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2967	163.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1565	1567	GCA	209;212;206	G,T;C;A	208,1;212;206	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3890	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2967	163.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1568	1570	ATC	204;205;204	A;T,C;C	204;204,1;204	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3890	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2967	163.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1580	1582	GTG	200;201;204	G;T;G,C	200;201;203,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3890	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2967	163.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1580	1582	GTG	200;201;204	G;T;G,C	200;201;203,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3890	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2967	163.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2084	2086	ACC	232;231;233	A;C;C,T,A	232;231;231,1,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3890	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2967	163.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2138	2140	GCG	234;233;234	G;C,G;G,T	234;232,1;233,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3890	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2967	163.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2138	2140	GCG	234;233;234	G;C,G;G,T	234;232,1;233,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3890	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2967	163.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2261	2263	GGC	215;218;219	G;G;C	215;218;219	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3890	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2967	163.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2270	2272	GGC	215;215;218	G;G;C,T	215;215;217,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3890	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2967	163.3	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2288	2290	CTG	206;207;209	C;T;G,C	206;207;208,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5400	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3683	182.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1781	1783	CCG	241;242;242	C,A;C;G	240,1;242;242	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2418	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2399	125.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	669	671	GGC	161;163;164	G,A;G;C	160,1;163;164	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2418	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2399	125.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	851	851	C	202	C,T	201,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	T26A	NONSYN	76	78	ACC	320	322	GCC	257;258;259	G,A;C,T;C	255,1;256,1;258	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	K41D	NONSYN	121	123	AAA	365	367	GAC	249;250;249	G,A;A,C;C,A	248,1;249,1;248,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	T87A	NONSYN	259	261	ACT	503	505	GCT	183;182;179	G;C,T;T	183;181,1;179	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	509	511	AGC	174;173;173	A,C;G;C	173,1;173;173	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	V98I	NONSYN	292	294	GTC	536	538	ATC	170;170;165	A;T,G;C	170;169,1;165	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	601	602	CG	156;156	C;G	155;155	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	604	606	CAG	159;157;156	C;A;G	158;156;155	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	608	610	AAA	158;158;159	A;A;A,G,T	158;158;157,1,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	635	637	TAT	185;186;186	T;A,T;T,A,G	185;185,1;184,1,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	N134E	NONSYN	400	402	AAT	644	646	GAG	196;199;199	G;A;G	196;199;199	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	V135L	NONSYN	403	405	GTG	647	649	CTT	199;200;200	C,T;T,G;T	198,1;199,1;200	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	G140K	NONSYN	418	420	GGA	662	664	AAA	205;207;206	A,T;A,C;A	204,1;206,1;206	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	671	673	GAA	206;205;205	G;A,G;A	206;204,1;205	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	695	697	GCA	222;223;223	G;C;A,C,T	222;223;220,2,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	I209M	NONSYN	625	627	ATC	869	871	ATG	221;222;221	A;T;G,C	221;221;219,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	878	878	T	221	T	221	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	1	SNP	p	G120K	1	.	.	358	360	AAG	601	603	CGG	156;156;159	C;G;G	155;155;158	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	1	SNP	p	A121D	1	.	.	361	363	GAC	604	607	CGC	159;156;157	C;G;C	158;155;157	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2544	porB1b	1041	1041	95.52	porB1b.l15.c30.ctg.1	1432	203.6	1	SNP	p	D121N	0	.	.	361	363	GAC	604	607	CGC	159;156;157	C;G;C	158;155;157	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9974	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5403	229.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1298	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1596	101.3	1	SNP	p	V57M	1	.	.	169	171	ATG	802	804	ATG	234;237;239	A,C;T;G	232,1;236;238	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
